18-7-1-3　ⓔ文献

  1. 木内　英：日本におけるHIV関連神経認知障害 (HAND) の有病率と関連因子：J–HAND研究結果報告から．IASR, 2017; 38: 182–184.

  2. Antinori A, Arendt G, et al: Updated research nosology for HIV–associated neurocognitive disorders. Neurology, 2007; 69: 1789–1799.

  3. Nakagawa M, Izumo S, et al: HTLV–I–associated myelopathy: Analysis of 213 patients based on clinical features and laboratory findings. J Neurovirol, 1995; 1: 50–61.

  4. Sato T, Yagishita N, et al: Proposal of classification criteria for HTLV–1–associated myelopathy/tropical spastic paraparesis disease activity. Front Microbiol, 2018; 9: 1651.

  5. Sato T, Coler–Reilly A, et al: CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV–1–associated myelopathy/tropical spastic paraparesis. PLoS Negl Trop Dis, 2013; 7: e2479.